Apollo Hospitals Enterprise Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Evolution and Price Movement

The stock closed at ₹7,042.60 on 1 Jan 2026, up from the previous close of ₹6,989.30, marking a daily increase of 0.76%. The intraday range was between ₹6,954.05 and ₹7,145.95, indicating some volatility but a general upward bias. The 52-week high stands at ₹8,099.00, while the 52-week low is ₹6,002.15, placing the current price closer to the upper end of its annual range.

Technically, the trend has shifted from mildly bearish to sideways, signalling a pause in the previous downtrend and potential consolidation. This transition is critical as it suggests that the bears’ momentum is waning, but the bulls have yet to establish a decisive uptrend.

MACD and Momentum Oscillators: Divergent Signals

The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly chart and mildly bearish on the monthly chart. This indicates that while short-term momentum is weak, longer-term momentum is only slightly negative, reflecting a cautious market stance. The bearish weekly MACD suggests that recent price gains may lack strong underlying momentum, warranting vigilance for potential reversals.

Conversely, the Relative Strength Index (RSI) shows no clear signal on both weekly and monthly timeframes, hovering in a neutral zone. This lack of directional RSI signal implies that the stock is neither overbought nor oversold, consistent with the sideways trend and consolidation phase.

Moving Averages and Bollinger Bands: Signs of Mild Bullishness

Daily moving averages have turned mildly bullish, signalling that short-term price averages are beginning to support upward price movement. This is a positive development, suggesting that buyers are gradually gaining control in the near term.

Bollinger Bands present a mixed picture: bearish on the weekly timeframe but mildly bullish on the monthly. The weekly bearishness indicates recent price pressure and volatility, while the monthly mild bullishness hints at a longer-term stabilisation or potential recovery. This divergence underscores the importance of monitoring price action closely over different time horizons.

Additional Momentum Indicators: KST, Dow Theory, and OBV

The Know Sure Thing (KST) indicator remains bearish on the weekly chart and mildly bearish on the monthly, reinforcing the cautious stance on momentum. KST’s bearish weekly reading aligns with the MACD’s short-term weakness, suggesting that momentum has not yet fully recovered.

Dow Theory readings are mildly bullish on the weekly timeframe but mildly bearish on the monthly, reflecting a nuanced market interpretation. The weekly mild bullishness may indicate short-term accumulation or optimism, while the monthly bearishness suggests that the longer-term trend remains under pressure.

On-balance volume (OBV) is mildly bullish weekly but mildly bearish monthly, signalling that volume trends support short-term price gains but do not yet confirm a sustained long-term uptrend. This volume-price divergence is typical during consolidation phases and warrants close observation for confirmation of trend direction.

Comparative Performance: Apollo Hospitals vs. Sensex

When analysing returns relative to the benchmark Sensex, Apollo Hospitals has underperformed in the short term but outperformed significantly over longer horizons. Year-to-date and one-year returns for Apollo Hospitals are negative at -3.48%, compared to Sensex’s robust 9.06% gain. Similarly, one-month and one-week returns show declines of -3.36% and -1.80% respectively, versus Sensex’s modest losses of -0.49% and -0.22%.

However, over three, five, and ten-year periods, Apollo Hospitals has delivered impressive compounded returns of 57.25%, 192.07%, and 381.45%, substantially outperforming the Sensex’s 40.07%, 78.47%, and 226.30% respectively. This long-term outperformance highlights the company’s strong fundamentals and growth trajectory despite recent technical headwinds.

Mojo Score and Rating Revision

MarketsMOJO has revised Apollo Hospitals’ Mojo Grade from Buy to Hold as of 24 Nov 2025, reflecting the recent technical and momentum shifts. The current Mojo Score stands at 61.0, indicating moderate confidence in the stock’s near-term prospects. The Market Cap Grade remains at 1, signalling the company’s large-cap status but also suggesting limited upside from a market capitalisation perspective.

This downgrade to Hold aligns with the mixed technical signals and sideways trend, advising investors to adopt a cautious stance and await clearer directional confirmation before increasing exposure.

Investor Implications and Outlook

The current technical landscape for Apollo Hospitals Enterprise Ltd. suggests a period of consolidation following a mild bearish phase. The mixed signals from MACD, RSI, moving averages, and volume indicators imply that the stock is at a technical crossroads. Investors should monitor key support levels near ₹6,950 and resistance around ₹7,150 to gauge the next directional move.

Given the sideways trend and neutral RSI, a breakout above the recent high of ₹7,145.95 accompanied by improving volume could signal a resumption of the uptrend. Conversely, a failure to hold support levels may lead to renewed selling pressure.

Long-term investors may find comfort in the company’s strong historical returns and market leadership in the hospital sector, but near-term caution is warranted due to the technical uncertainty and recent Mojo Grade downgrade.

Overall, Apollo Hospitals remains a fundamentally sound large-cap stock with a mixed technical outlook. Investors should balance the company’s growth potential against the current momentum challenges and consider portfolio diversification strategies accordingly.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →